Venous disease and pulmonary embolism

Gregory (Greg) Moneta, Mathew I. Foley

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in the United States. Although precise figures are difficult to obtain as a consequence of undiagnosed cases, the annual incidence of VTE has been estimated at 71 and 117 per 100,000 by two different recent retrospective population-based studies (Worcester and Olmstead Counties).1,2 Their reported annual incidences for deep venous thrombosis were nearly identical (48 per 100,000), but for pulmonary embolus (PE) there was great disparity (23 versus 69 per 100,000). This difference was believed to be secondary to the threefold higher rate of autopsy acquisition in Olmstead County as compared to the U.S. average.2 In-hospital case-fatality rates were also different, 12% versus 28%, respectively. Based on the Worcester data, Anderson and Wheeler have estimated the prevalence of clinically significant VTE at 600,000 cases per year, with as many as two-thirds of these being undiagnosed.3 Deep venous thrombosis (DVT) poses not only the immediate threat of pulmonary embolus (PE) but chronic disability secondary to venous insufficiency as well. PE is estimated to be responsible for the deaths of 50,000 to 100,000 persons per year in U.S. hospitals who would not otherwise be expected to die of their underlying disease process.4-6 Despite this awareness and evidence for the efficacy of various forms of prophylaxis, attention toward prevention remains inadequate.7

    Original languageEnglish (US)
    Title of host publicationSurgery: Basic Science and Clinical Evidence: Second Edition
    PublisherSpringer New York
    Pages1429-1456
    Number of pages28
    ISBN (Print)9783540297338
    DOIs
    StatePublished - 2008

    Fingerprint

    Venous Thromboembolism
    Embolism
    Pulmonary Embolism
    Venous Thrombosis
    Lung
    Venous Insufficiency
    Mortality
    Incidence
    Autopsy
    Morbidity
    Population

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Moneta, G. G., & Foley, M. I. (2008). Venous disease and pulmonary embolism. In Surgery: Basic Science and Clinical Evidence: Second Edition (pp. 1429-1456). Springer New York. https://doi.org/10.1007/978-0-387-68113-9_68

    Venous disease and pulmonary embolism. / Moneta, Gregory (Greg); Foley, Mathew I.

    Surgery: Basic Science and Clinical Evidence: Second Edition. Springer New York, 2008. p. 1429-1456.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Moneta, GG & Foley, MI 2008, Venous disease and pulmonary embolism. in Surgery: Basic Science and Clinical Evidence: Second Edition. Springer New York, pp. 1429-1456. https://doi.org/10.1007/978-0-387-68113-9_68
    Moneta GG, Foley MI. Venous disease and pulmonary embolism. In Surgery: Basic Science and Clinical Evidence: Second Edition. Springer New York. 2008. p. 1429-1456 https://doi.org/10.1007/978-0-387-68113-9_68
    Moneta, Gregory (Greg) ; Foley, Mathew I. / Venous disease and pulmonary embolism. Surgery: Basic Science and Clinical Evidence: Second Edition. Springer New York, 2008. pp. 1429-1456
    @inbook{a994ff555424463d8f5f7387475395fb,
    title = "Venous disease and pulmonary embolism",
    abstract = "Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in the United States. Although precise figures are difficult to obtain as a consequence of undiagnosed cases, the annual incidence of VTE has been estimated at 71 and 117 per 100,000 by two different recent retrospective population-based studies (Worcester and Olmstead Counties).1,2 Their reported annual incidences for deep venous thrombosis were nearly identical (48 per 100,000), but for pulmonary embolus (PE) there was great disparity (23 versus 69 per 100,000). This difference was believed to be secondary to the threefold higher rate of autopsy acquisition in Olmstead County as compared to the U.S. average.2 In-hospital case-fatality rates were also different, 12{\%} versus 28{\%}, respectively. Based on the Worcester data, Anderson and Wheeler have estimated the prevalence of clinically significant VTE at 600,000 cases per year, with as many as two-thirds of these being undiagnosed.3 Deep venous thrombosis (DVT) poses not only the immediate threat of pulmonary embolus (PE) but chronic disability secondary to venous insufficiency as well. PE is estimated to be responsible for the deaths of 50,000 to 100,000 persons per year in U.S. hospitals who would not otherwise be expected to die of their underlying disease process.4-6 Despite this awareness and evidence for the efficacy of various forms of prophylaxis, attention toward prevention remains inadequate.7",
    author = "Moneta, {Gregory (Greg)} and Foley, {Mathew I.}",
    year = "2008",
    doi = "10.1007/978-0-387-68113-9_68",
    language = "English (US)",
    isbn = "9783540297338",
    pages = "1429--1456",
    booktitle = "Surgery: Basic Science and Clinical Evidence: Second Edition",
    publisher = "Springer New York",

    }

    TY - CHAP

    T1 - Venous disease and pulmonary embolism

    AU - Moneta, Gregory (Greg)

    AU - Foley, Mathew I.

    PY - 2008

    Y1 - 2008

    N2 - Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in the United States. Although precise figures are difficult to obtain as a consequence of undiagnosed cases, the annual incidence of VTE has been estimated at 71 and 117 per 100,000 by two different recent retrospective population-based studies (Worcester and Olmstead Counties).1,2 Their reported annual incidences for deep venous thrombosis were nearly identical (48 per 100,000), but for pulmonary embolus (PE) there was great disparity (23 versus 69 per 100,000). This difference was believed to be secondary to the threefold higher rate of autopsy acquisition in Olmstead County as compared to the U.S. average.2 In-hospital case-fatality rates were also different, 12% versus 28%, respectively. Based on the Worcester data, Anderson and Wheeler have estimated the prevalence of clinically significant VTE at 600,000 cases per year, with as many as two-thirds of these being undiagnosed.3 Deep venous thrombosis (DVT) poses not only the immediate threat of pulmonary embolus (PE) but chronic disability secondary to venous insufficiency as well. PE is estimated to be responsible for the deaths of 50,000 to 100,000 persons per year in U.S. hospitals who would not otherwise be expected to die of their underlying disease process.4-6 Despite this awareness and evidence for the efficacy of various forms of prophylaxis, attention toward prevention remains inadequate.7

    AB - Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in the United States. Although precise figures are difficult to obtain as a consequence of undiagnosed cases, the annual incidence of VTE has been estimated at 71 and 117 per 100,000 by two different recent retrospective population-based studies (Worcester and Olmstead Counties).1,2 Their reported annual incidences for deep venous thrombosis were nearly identical (48 per 100,000), but for pulmonary embolus (PE) there was great disparity (23 versus 69 per 100,000). This difference was believed to be secondary to the threefold higher rate of autopsy acquisition in Olmstead County as compared to the U.S. average.2 In-hospital case-fatality rates were also different, 12% versus 28%, respectively. Based on the Worcester data, Anderson and Wheeler have estimated the prevalence of clinically significant VTE at 600,000 cases per year, with as many as two-thirds of these being undiagnosed.3 Deep venous thrombosis (DVT) poses not only the immediate threat of pulmonary embolus (PE) but chronic disability secondary to venous insufficiency as well. PE is estimated to be responsible for the deaths of 50,000 to 100,000 persons per year in U.S. hospitals who would not otherwise be expected to die of their underlying disease process.4-6 Despite this awareness and evidence for the efficacy of various forms of prophylaxis, attention toward prevention remains inadequate.7

    UR - http://www.scopus.com/inward/record.url?scp=84892233032&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84892233032&partnerID=8YFLogxK

    U2 - 10.1007/978-0-387-68113-9_68

    DO - 10.1007/978-0-387-68113-9_68

    M3 - Chapter

    AN - SCOPUS:84892233032

    SN - 9783540297338

    SP - 1429

    EP - 1456

    BT - Surgery: Basic Science and Clinical Evidence: Second Edition

    PB - Springer New York

    ER -